 |
|
|
| |
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, announces today the opening of their new global corporate headquarters in Newcastle-Upon-Tyne, UK.
Aesica has more than trebled in size since being founded in 2004 and has built a customer base that includes the world's largest pharmaceutical companies, leading generics manufacturers and emerging pharma companies. The new headquarters, which is located close to Newcastle city centre, will house the key business functions of the company including, the CEO's office and Executive team, and the Finance, Business Development and HR teams. With a central location, close to all amenities and international transport links, the new office will enable Aesica to better serve its customers and continue to grow its API and formulated products business.
The office will also support Aesica's three manufacturing and packaging sites in Cramlington, Ponders End and Queenborough, UK, as well as the Company's recently established US commercial presence.
Dr Robert Hardy, CEO of Aesica, said: "Aesica has grown significantly in recent years both organically and through successive large-scale acquisitions of manufacturing sites. The opening of this new headquarters is testament to our continued unwavering commitment to building a truly global business and becoming the number one supplier of APIs and formulated products to the pharmaceutical industry."
<< volver |
|
|
|
|
|
 |
|
 |
